1. World Health Organization
27 November 2019
Countries using and planning to introduce IPV October 2014 status report
This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV).
Information here is updated monthly based on information shared by WHO and UNICEF Regional Offices. Please contact with any questions or updates on this data.
Definitions
Formal decision to introduce: The country has documentation of its decision to introduce IPV which has been verified by the relevant WHO Regional Office, or for GAVI eligible countries, a complete application for IPV has been submitted to the GAVI Secretariat.
Intent to introduce: The country has informally indicated that it plans to introduce IPV, e.g. planning an application to GAVI, or by requesting technical assistance to develop an IPV introduction plan.
Tracking these decisions and informal intents provide an indication of the global trend towards meeting the targets of the Polio Eradication and Endgame Strategic Plan.

2. World Health Organization
27 November 2019
Countries using IPV vaccine to date and formal decision/intent to introduce
Introduced: Albania Andorra Australia Austria Bahrain Belarus Belgium Bosnia and Herzegovina Brazil Brunei Darussalam Bulgaria Canada Costa Rica Croatia Cyprus Czech Republic (the) Denmark Estonia Finland France Germany Greece Hungary Iceland Ireland Israel Italy Japan Jordan Kazakhstan Kuwait Latvia Lebanon Libya Lithuania Luxembourg Malaysia Malta Marshall Islands (the) Mexico Micronesia (Federated States of) Monaco Montenegro Nepal Netherlands (the) New Zealand Niue Norway Oman Palau Panama Peru Poland Portugal Qatar Rep of Korea Romania Russian Federation (the) San Marino Saudi Arabia Singapore Slovakia Slovenia South Africa Spain Sweden Switzerland Syrian Arab Republic (the) Tunisia Turkey Ukraine United Arab Emirates (the) United Kingdom of Great Britain and Northern Ireland (the) United States of America (the) Uruguay
Formal Commitment:
: Afghanistan Angola Argentina Armenia Azerbaijan Bahamas (the) Bangladesh Belize Benin Bhutan Burkina Faso Burundi Cambodia Cameroon Central African Republic (the) Chad Colombia Comoros (the) Congo (the) Cote d'Ivoire Cuba DPR Korea DR Congo Eritrea Ethiopia Gabon Gambia (the) Georgia Ghana Guatemala Guinea Guinea-Bissau India Indonesia Iraq Kenya Kiribati Kyrgyzstan Lao People's Democratic Republic (the) Lesotho Liberia Madagascar Malawi Maldives Mali Mauritania Mongolia Morocco Mozambique Myanmar Namibia Nicaragua Niger (the) Nigeria Pakistan Papua New Guinea Republic of Moldova (the) Rwanda Sao Tome and Principe Senegal Sierra Leone Solomon Islands Somalia South Sudan Sri Lanka Sudan (the) Tajikistan The former Yugoslav Republic of Macedonia Timor-Leste Togo Uganda United Republic of Tanzania (the) Uzbekistan Viet Nam Yemen Zambia Zimbabwe
Intent to introduce:
2015: Algeria Barbados Bolivia (Plurinational State of) Botswana China Cook Islands Djibouti Dominica Dominican Republic (the) Egypt El Salvador Equatorial Guinea Fiji Grenada Guyana Haiti Iran (Islamic Republic of) Jamaica Mauritius Paraguay Philippines (the) Saint Vincent and the Grenadines Samoa Serbia Seychelles Suriname Swaziland Thailand Turkmenistan
No plans/ Not introduced:
Antigua and Barbuda Cabo Verde Chile Ecuador Honduras Nauru Saint Kitts and Nevis Saint Lucia Tonga Trinidad and Tobago Tuvalu Vanuatu Venezuela (Bolivarian Republic of)
Not Available, Not Introduced /No Plans (13 countries,7%)
Not applicable
Intent to Introduce in (29 countries, 15%)
Formal commitment to Introduce in (77 countries, 39%)
Introduced to date (75 countries, 39%)
Data Source: WHO/IVB Database, as at 01 October Data of slide: 02 October 2014 Map production: Immunization Vaccines and Biologicals, (IVB), World Health Organization
Since January 2013, the following countries have introduced IPV: Kazakhstan (July 2013); Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (2014), Nepal (Sep 2014) and Tunisia (Sep 2014)
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.
 WHO All rights reserved

3. World Health Organization
Countries using IPV vaccine to date and introductions planned according to GAVI eligibility status
27 November 2019
Introduced: Albania Andorra Australia Austria Bahrain Belarus Belgium Bosnia and Herzegovina Brazil Brunei Darussalam Bulgaria Canada Costa Rica Croatia Cyprus Czech Republic (the) Denmark Estonia Finland France Germany Greece Hungary Iceland Ireland Israel Italy Japan Jordan Kazakhstan Kuwait Latvia Lebanon Libya Lithuania Luxembourg Malaysia Malta Marshall Islands (the) Mexico Micronesia (Federated States of) Monaco Montenegro Nepal Netherlands (the) New Zealand Niue Norway Oman Palau Panama Peru Poland Portugal Qatar Rep of Korea Romania Russian Federation (the) San Marino Saudi Arabia Singapore Slovakia Slovenia South Africa Spain Sweden Switzerland Syrian Arab Republic (the) Tunisia Turkey Ukraine United Arab Emirates (the) United Kingdom of Great Britain and Northern Ireland (the) United States of America (the) Uruguay
GAVI countries with Formal commitment: Afghanistan Angola Armenia Azerbaijan Bangladesh Benin Bhutan Burkina Faso Burundi Cambodia Cameroon Central African Republic (the) Chad Comoros (the) Congo (the) Cote d'Ivoire Cuba DPR Korea DR Congo Eritrea Ethiopia Gambia (the) Georgia Ghana Guinea Guinea-Bissau India Indonesia Kenya Kiribati Kyrgyzstan Lao People's Democratic Republic (the) Lesotho Liberia Madagascar Malawi Mali Mauritania Mongolia Mozambique Myanmar Nicaragua Niger (the) Nigeria Pakistan Papua New Guinea Republic of Moldova (the) Rwanda Sao Tome and Principe Senegal Sierra Leone Solomon Islands Somalia South Sudan Sri Lanka Sudan (the) Tajikistan Timor-Leste Togo Uganda United Republic of Tanzania (the) Uzbekistan Viet Nam Yemen Zambia Zimbabwe
GAVI Countries with Intent: Bolivia (Plurinational State of) Djibouti Guyana Haiti
Non GAVI with formal commitment: Argentina Bahamas (the) Belize Colombia Gabon Guatemala Iraq Maldives Morocco Namibia The former Yugoslav Republic of Macedonia
Non GAVI with Intent: Algeria Barbados Botswana China Cook Islands Dominica Dominican Republic (the) Egypt El Salvador Equatorial Guinea Fiji Grenada Iran (Islamic Republic of) Jamaica Mauritius Paraguay Philippines (the) Saint Vincent and the Grenadines Samoa Serbia Seychelles Suriname Swaziland Thailand Turkmenistan
No plans/ Not introduced: Antigua and Barbuda Cabo Verde Chile Ecuador Honduras Nauru Saint Kitts and Nevis Saint Lucia Tonga Trinidad and Tobago Tuvalu Vanuatu Venezuela (Bolivarian Republic of)
Not Available, Not Introduced /No Plans (13 countries, 7%)
Not applicable
GAVI countries with formal commitment to introduce in (66 countries, 34%)
Introduced to date (75 countries, 39%)
GAVI countries with intent to introduce in 2015 (4 countries, 2%)
Non GAVI countries with formal commitment to introduce in (11 countries, 5%)
Non GAVI countries with intent to introduce in 2015 (25 countries, 13%)
Data Source: WHO/IVB Database, as at 01 October Data of slide: 02 October 2014 Map production: Immunization Vaccines and Biologicals, (IVB), World Health Organization
Since January 2013, the following countries have introduced IPV: Kazakhstan (July 2013); Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (2014), Nepal (Sep 2014) and Tunisia (Sep 2014)
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.
 WHO All rights reserved